KPC Pharmaceuticals Inc Relative Valuation - KPC Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.71 CNY -3.62%

Market Cap: ¥8.9B

	KPC Pharmaceuticals Inc SSE:600422	CN
	Manorama Industries Ltd NSE:MANORAMA	IN
	Beijing Enterprises Water Group Ltd HKEX:371	HK
	Riso Kagaku Corp TSE:6413	JP

Relative Value

The Relative Value of one KPC Pharmaceuticals Inc stock under the Base Case scenario is hidden CNY. Compared to the current market price of 11.71 CNY, KPC Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

KPC Pharmaceuticals Inc Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
CN		KPC Pharmaceuticals Inc SSE:600422	8.9B CNY	1.2	16.7	10.7	10.7
US		Eli Lilly and Co NYSE:LLY	856.7B USD	13.1	41.5	28	29.9
US		Johnson & Johnson NYSE:JNJ	566.8B USD	6	21.1	14.7	18.1
CH		Roche Holding AG SIX:ROG	243.3B CHF	4	18.9	11.2	12.6
UK		AstraZeneca PLC LSE:AZN	216.4B GBP	4.9	28.3	15.7	22.2
US		Merck & Co Inc NYSE:MRK	282.6B USD	4.3	15.5	9.6	11.7
CH		Novartis AG SIX:NOVN	222.2B CHF	5.1	20.5	12.7	16.3
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
DK		Novo Nordisk A/S CSE:NOVO B	1.1T DKK	3.4	10.3	7.7	9
US		Pfizer Inc NYSE:PFE	153.4B USD	2.5	19.7	7.6	10.1
US		Bristol-Myers Squibb Co NYSE:BMY	115.7B USD	2.4	16.4	7	8.6

				Revenue Growth	P/S to Growth
CN		KPC Pharmaceuticals Inc SSE:600422	Average P/S: 13.6 1.2	6%	0.2
US		Eli Lilly and Co NYSE:LLY	13.1	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6	6%	1
CH		Roche Holding AG SIX:ROG	4	4%	1
UK		AstraZeneca PLC LSE:AZN	4.9	7%	0.7
US		Merck & Co Inc NYSE:MRK	4.3	5%	0.9
CH		Novartis AG SIX:NOVN	5.1	5%	1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.4	2%	1.7
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.4	-5%	N/A

				Earnings Growth	PEG
CN		KPC Pharmaceuticals Inc SSE:600422	Average P/E: 20.9 16.7	9%	1.9
US		Eli Lilly and Co NYSE:LLY	41.5	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.1	7%	3
CH		Roche Holding AG SIX:ROG	18.9	14%	1.3
UK		AstraZeneca PLC LSE:AZN	28.3	26%	1.1
US		Merck & Co Inc NYSE:MRK	15.5	14%	1.1
CH		Novartis AG SIX:NOVN	20.5	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10.3	1%	10.3
US		Pfizer Inc NYSE:PFE	19.7	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	16.4	16%	1

				EBITDA Growth	EV/EBITDA to Growth
CN		KPC Pharmaceuticals Inc SSE:600422	Average EV/EBITDA: 45.5 10.7	11%	1
US		Eli Lilly and Co NYSE:LLY	28	22%	1.3
US		Johnson & Johnson NYSE:JNJ	14.7	2%	7.4
CH		Roche Holding AG SIX:ROG	11.2	6%	1.9
UK		AstraZeneca PLC LSE:AZN	15.7	13%	1.2
US		Merck & Co Inc NYSE:MRK	9.6	3%	3.2
CH		Novartis AG SIX:NOVN	12.7	5%	2.5
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.7	1%	7.7
US		Pfizer Inc NYSE:PFE	7.6	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
CN		KPC Pharmaceuticals Inc SSE:600422	Average EV/EBIT: 99.1 10.7	13%	0.8
US		Eli Lilly and Co NYSE:LLY	29.9	22%	1.4
US		Johnson & Johnson NYSE:JNJ	18.1	6%	3
CH		Roche Holding AG SIX:ROG	12.6	6%	2.1
UK		AstraZeneca PLC LSE:AZN	22.2	21%	1.1
US		Merck & Co Inc NYSE:MRK	11.7	6%	2
CH		Novartis AG SIX:NOVN	16.3	9%	1.8
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	9	2%	4.5
US		Pfizer Inc NYSE:PFE	10.1	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.6	-7%	N/A

KPC Pharmaceuticals Inc
SSE:600422

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples
KPC Pharmaceuticals Inc Competitors

See Also

Company

Help

Tools

Stocks

KPC Pharmaceuticals Inc SSE:600422

Relative Value

Valuation Multiples

Multiples Across Competitors

Competitors Multiples KPC Pharmaceuticals Inc Competitors

See Also

Company

Help

Tools

Stocks

KPC Pharmaceuticals Inc
SSE:600422

Competitors Multiples
KPC Pharmaceuticals Inc Competitors